Introduction: The Shift from Batch to Continuous-Flow ProcessingIn modern pharmaceutical and crop-protection manufacturing, process intensification has transitioned from an exploratory academic concept into a critical commercial strategy. As target drug molecules become increasingly complex, traditi
Introduction: The Sustainability Mandate in Modern Fine ChemicalsIn the contemporary lifecycle management of active pharmaceutical ingredients (APIs) and advanced crop-protection agents, structural optimization is no longer judged solely on clinical or biological efficacy. Global regulatory initiati
Introduction: The Regulatory Imperative for Structural PurityIn the modern pharmaceutical manufacturing landscape, the criteria for raw material selection have evolved far beyond basic commercial availability and gross assay percentages. Regulatory frameworks, such as the International Council for H